1. Home
  2. FBDT vs CVM Comparison

FBDT vs CVM Comparison

Compare FBDT & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FBDT

First Breach Inc. Common Stock

N/A

Current Price

$0.89

Market Cap

32.2M

Sector

Industrials

ML Signal

N/A

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$1.65

Market Cap

30.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBDT
CVM
Founded
N/A
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.2M
30.1M
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
FBDT
CVM
Price
$0.89
$1.65
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.5M
108.3K
Earning Date
N/A
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.45
52 Week Low
$0.61
$0.89
52 Week High
$1.25
$10.83

Technical Indicators

Market Signals
Indicator
FBDT
CVM
Relative Strength Index (RSI) 60.70 54.53
Support Level $0.71 $0.95
Resistance Level $1.25 $1.59
Average True Range (ATR) 0.14 0.08
MACD 0.02 -0.02
Stochastic Oscillator 44.06 36.07

Price Performance

Historical Comparison
FBDT
CVM

About FBDT First Breach Inc. Common Stock

First Breach Inc is an American defense technologies company focused on manufacturing match-grade ammunition components, finished ammunition, and developing unmanned aerial systems for commercial, law enforcement, and military markets. Its ammunition operations include the in-house production of brass cups, casings, projectiles, lead cores, lead wire, and completed ammunition. The company is also developing U.S.-made unmanned aerial systems incorporating robotics, intelligence, surveillance and reconnaissance (ISR), sensor, and precision manufacturing technologies for defense, homeland security, law enforcement, and commercial applications.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: